|
Oct 9
|
Nexstim Oyj (FRA:5NX) (H1 2024) Earnings Call Highlights: Strong Revenue Growth and Improved ...
|
|
Jun 18
|
Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act
|
|
May 8
|
Finnish Hospital Orders Nexstim NBS System 5
|
|
May 6
|
Health Canada Approves Nexstim NBS 6 System for Treatment of MDD
|
|
Jan 10
|
Nexstim Receives NBS System 5 Order from Healthcare Services Group in the US
|
|
Jan 4
|
Nexstim Agrees on a Strategic Investment into a Management Services Organization of a New Jersey Based Clinic Providing Treatments for Depression Patients
|
|
Jan 2
|
Insider Information, profit warning: Nexstim Oyj specifies its guidance for 2023
|
|
Dec 29
|
Nexstim receives Nexstim NBS System 5 order from Distributor in Europe
|
|
Dec 22
|
Nexstim Plc: Correction to Company Announcement: Nexstim Plc’s Financial Information in 2024 and Updated Disclosure Policy
|
|
Dec 22
|
Nexstim receives Nexstim NBS System 5 order from Europe for Neurosurgery and Neuroscience Use
|
|
Dec 21
|
Nexstim Plc’s Financial Information in 2024 and Updated Disclosure Policy
|
|
Dec 21
|
Nexstim Receives Order for Two NBS 6 Systems from Distributor
|
|
Dec 20
|
Center for Integrative Neuroscience in MI, United States Orders Nexstim NBS 6 System
|
|
Dec 19
|
Hospital in Germany Orders Nexstim NBS System 5
|
|
Dec 4
|
Nexstim Releases New System Functionalities for Research Use in Europe
|
|
Nov 30
|
Nexstim Plc Changes Certified Advisor to Carnegie Investment Bank AB (publ)
|
|
Sep 26
|
Nexstim Receives Order for NBS 5 System with NexSpeech®
|
|
Aug 10
|
Nexstim Plc agreed on a loan with Nordea to fund investments into growth
|